{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:19:33Z","timestamp":1788279573790,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2026,9,20]]},"DOI":"10.1038\/s41416-026-03526-7","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T10:17:30Z","timestamp":1782469050000},"page":"873-881","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rewiring of de novo serine synthesis supports tumorigenesis under deficiency of TET2"],"prefix":"10.1038","volume":"135","author":[{"given":"Ke","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keqiang","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhilong","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1891-458X","authenticated-orcid":false,"given":"Jing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"3526_CR1","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nrg.2017.33","volume":"18","author":"X Wu","year":"2017","unstructured":"Wu X, Zhang Y. TET-mediated active DNA demethylation: mechanism, function and beyond. Nat Rev Genet. 2017;18:517\u201334.","journal-title":"Nat Rev Genet"},{"key":"3526_CR2","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41580-019-0159-6","volume":"20","author":"MVC Greenberg","year":"2019","unstructured":"Greenberg MVC, Bourc\u2019his D. The diverse roles of DNA methylation in mammalian development and disease. Nat Rev Mol cell Biol. 2019;20:590\u2013607.","journal-title":"Nat Rev Mol cell Biol"},{"key":"3526_CR3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41576-020-00287-8","volume":"22","author":"A Parry","year":"2021","unstructured":"Parry A, Rulands S, Reik W. Active turnover of DNA methylation during cell fate decisions. Nat Rev Genet. 2021;22:59\u201366.","journal-title":"Nat Rev Genet"},{"key":"3526_CR4","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1056\/NEJMoa0810069","volume":"360","author":"F Delhommeau","year":"2009","unstructured":"Delhommeau F, Dupont S, Della Valle V, James C, Trannoy S, Mass\u00e9 A, et al. Mutation in TET2 in myeloid cancers. N Engl J Med. 2009;360:2289\u2013301.","journal-title":"N Engl J Med"},{"key":"3526_CR5","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.trecan.2020.12.011","volume":"7","author":"JK Bray","year":"2021","unstructured":"Bray JK, Dawlaty MM, Verma A, Maitra A. Roles and regulations of TET enzymes in solid tumors. Trends cancer. 2021;7:635\u201346.","journal-title":"Trends cancer"},{"key":"3526_CR6","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1182\/blood.2019791475","volume":"134","author":"CJ Lio","year":"2019","unstructured":"Lio CJ, Yuita H, Rao A. Dysregulation of the TET family of epigenetic regulators in lymphoid and myeloid malignancies. Blood. 2019;134:1487\u201397.","journal-title":"Blood"},{"key":"3526_CR7","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.tig.2014.07.005","volume":"30","author":"Y Huang","year":"2014","unstructured":"Huang Y, Rao A. Connections between TET proteins and aberrant DNA modification in cancer. Trends Genet : TIG. 2014;30:464\u201374.","journal-title":"Trends Genet : TIG"},{"key":"3526_CR8","doi-asserted-by":"publisher","first-page":"4509","DOI":"10.1182\/blood-2010-12-325241","volume":"118","author":"Z Li","year":"2011","unstructured":"Li Z, Cai X, Cai CL, Wang J, Zhang W, Petersen BE, et al. Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies. Blood. 2011;118:4509\u201318.","journal-title":"Blood"},{"key":"3526_CR9","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.cell.2017.07.032","volume":"170","author":"L Cimmino","year":"2017","unstructured":"Cimmino L, Dolgalev I, Wang Y, Yoshimi A, Martin GH, Wang J, et al. Restoration of TET2 function blocks aberrant self-renewal and leukemia progression. Cell. 2017;170:1079\u20131095.e1020.","journal-title":"Cell"},{"key":"3526_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/pnasnexus\/pgae504","volume":"3","author":"Y Jin","year":"2024","unstructured":"Jin Y, Rao K, Zheng J, Zhang X, Luo Y, He J. Deficiency of TET2-mediated KMT2D self-transcription confers a targetable vulnerability in hepatocellular carcinoma. PNAS Nexus. 2024;3:pgae504.","journal-title":"PNAS Nexus"},{"key":"3526_CR11","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nature25434","volume":"554","author":"Q Shen","year":"2018","unstructured":"Shen Q, Zhang Q, Shi Y, Shi Q, Jiang Y, Gu Y, et al. Tet2 promotes pathogen infection-induced myelopoiesis through mRNA oxidation. Nature. 2018;554:123\u20137.","journal-title":"Nature"},{"key":"3526_CR12","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41421-023-00567-7","volume":"9","author":"J He","year":"2023","unstructured":"He J, Lin M, Zhang X, Zhang R, Tian T, Zhou Y, et al. TET2 is required to suppress mTORC1 signaling through urea cycle with therapeutic potential. Cell Discov. 2023;9:84.","journal-title":"Cell Discov"},{"key":"3526_CR13","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.stem.2023.07.001","volume":"30","author":"Y Li","year":"2023","unstructured":"Li Y, Xue M, Deng X, Dong L, Nguyen LXT, Ren L, et al. TET2-mediated mRNA demethylation regulates leukemia stem cell homing and self-renewal. Cell Stem cell. 2023;30:1072\u20131090.e1010.","journal-title":"Cell Stem cell"},{"key":"3526_CR14","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41594-020-00526-w","volume":"28","author":"C He","year":"2021","unstructured":"He C, Bozler J, Janssen KA, Wilusz JE, Garcia BA, Schorn AJ, et al. TET2 chemically modifies tRNAs and regulates tRNA fragment levels. Nat Struct Mol Biol. 2021;28:62\u201370.","journal-title":"Nat Struct Mol Biol"},{"key":"3526_CR15","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/s41586-024-07969-x","volume":"634","author":"Z Zou","year":"2024","unstructured":"Zou Z, Dou X, Li Y, Zhang Z, Wang J, Gao B, et al. RNA m(5)C oxidation by TET2 regulates chromatin state and leukaemogenesis. Nature. 2024;634:986\u201394.","journal-title":"Nature"},{"key":"3526_CR16","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/s41588-018-0060-9","volume":"50","author":"D Guallar","year":"2018","unstructured":"Guallar D, Bi X, Pardavila JA, Huang X, Saenz C, Shi X, et al. RNA-dependent chromatin targeting of TET2 for endogenous retrovirus control in pluripotent stem cells. Nat Genet. 2018;50:443\u201351.","journal-title":"Nat Genet"},{"key":"3526_CR17","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.tcb.2017.05.001","volume":"27","author":"AC Newman","year":"2017","unstructured":"Newman AC, Maddocks ODK. Serine and Functional Metabolites in Cancer. Trends cell Biol. 2017;27:645\u201357.","journal-title":"Trends cell Biol"},{"key":"3526_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2016.08.009","volume":"25","author":"GS Ducker","year":"2017","unstructured":"Ducker GS, Rabinowitz JD. One-Carbon Metabolism in Health and Disease. Cell Metab. 2017;25:27\u201342.","journal-title":"Cell Metab"},{"key":"3526_CR19","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1038\/s41594-024-01309-3","volume":"31","author":"J He","year":"2024","unstructured":"He J, Wang A, Zhao Q, Zou Y, Zhang Z, Sha N, et al. RNAi screens identify HES4 as a regulator of redox balance supporting pyrimidine synthesis and tumor growth. Nat Struct Mol Biol. 2024;31:1413\u201325.","journal-title":"Nat Struct Mol Biol"},{"key":"3526_CR20","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.tibs.2018.05.003","volume":"43","author":"P Kandasamy","year":"2018","unstructured":"Kandasamy P, Gyimesi G, Kanai Y, Hediger MA. Amino acid transporters revisited: New views in health and disease. Trends Biochem Sci. 2018;43:752\u201389.","journal-title":"Trends Biochem Sci"},{"key":"3526_CR21","first-page":"6416","volume":"362","author":"N Kory","year":"2018","unstructured":"Kory N, Wyant GA, Prakash G, Uit de Bos J, Bottanelli F, Pacold ME, et al. SFXN1 is a mitochondrial serine transporter required for one-carbon metabolism. Sci (N Y, NY). 2018;362:6416.","journal-title":"Sci (N Y, NY)"},{"key":"3526_CR22","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s42255-020-00329-9","volume":"3","author":"SL Geeraerts","year":"2021","unstructured":"Geeraerts SL, Heylen E, De Keersmaecker K, Kampen KR. The ins and outs of serine and glycine metabolism in cancer. Nat Metab. 2021;3:131\u201341.","journal-title":"Nat Metab"},{"key":"3526_CR23","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1083\/jcb.201604085","volume":"214","author":"KR Mattaini","year":"2016","unstructured":"Mattaini KR, Sullivan MR, Vander Heiden MG. The importance of serine metabolism in cancer. J cell Biol. 2016;214:249\u201357.","journal-title":"J cell Biol"},{"key":"3526_CR24","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/nature11540","volume":"491","author":"B Chaneton","year":"2012","unstructured":"Chaneton B, Hillmann P, Zheng L, Martin ACL, Maddocks ODK, Chokkathukalam A, et al. Serine is a natural ligand and allosteric activator of pyruvate kinase M2. Nature. 2012;491:458\u201362.","journal-title":"Nature"},{"key":"3526_CR25","doi-asserted-by":"publisher","first-page":"6904","DOI":"10.1073\/pnas.1204176109","volume":"109","author":"J Ye","year":"2012","unstructured":"Ye J, Mancuso A, Tong X, Ward PS, Fan J, Rabinowitz JD, et al. Pyruvate kinase M2 promotes de novo serine synthesis to sustain mTORC1 activity and cell proliferation. Proc Natl Acad Sci USA. 2012;109:6904\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3526_CR26","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.celrep.2015.12.053","volume":"14","author":"E Zhao","year":"2016","unstructured":"Zhao E, Ding J, Xia Y, Liu M, Ye B, Choi JH, et al. KDM4C and ATF4 cooperate in transcriptional control of amino acid metabolism. Cell Rep. 2016;14:506\u201319.","journal-title":"Cell Rep"},{"key":"3526_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109706","volume":"36","author":"X Li","year":"2021","unstructured":"Li X, Gracilla D, Cai L, Zhang M, Yu X, Chen X, et al. ATF3 promotes the serine synthesis pathway and tumor growth under dietary serine restriction. Cell Rep. 2021;36:109706.","journal-title":"Cell Rep"},{"key":"3526_CR28","doi-asserted-by":"publisher","first-page":"4316","DOI":"10.1172\/JCI129317","volume":"129","author":"YP Xu","year":"2019","unstructured":"Xu YP, Lv L, Liu Y, Smith MD, Li WC, Tan XM, et al. Tumor suppressor TET2 promotes cancer immunity and immunotherapy efficacy. J Clin Investig. 2019;129:4316\u201331.","journal-title":"J Clin Investig"},{"key":"3526_CR29","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/s41419-025-07745-3","volume":"16","author":"J He","year":"2025","unstructured":"He J, Lin M, Teng F, Sun X, Tian Z, Li J, et al. TET2 orchestrates YAP signaling to potentiate targetable vulnerability in hepatocellular carcinoma. Cell Death Dis. 2025;16:438.","journal-title":"Cell Death Dis"},{"key":"3526_CR30","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1158\/0008-5472.CAN-21-3013","volume":"82","author":"X Zhang","year":"2022","unstructured":"Zhang X, Li S, He J, Jin Y, Zhang R, Dong W, et al. TET2 suppresses VHL deficiency-driven clear cell renal cell carcinoma by inhibiting HIF signaling. Cancer Res. 2022;82:2097\u2013109.","journal-title":"Cancer Res"},{"key":"3526_CR31","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.molcel.2016.09.034","volume":"64","author":"C He","year":"2016","unstructured":"He C, Sidoli S, Warneford-Thomson R, Tatomer DC, Wilusz JE, Garcia BA, et al. High-resolution mapping of RNA-binding regions in the nuclear proteome of embryonic stem cells. Mol Cell. 2016;64:416\u201330.","journal-title":"Mol Cell"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03526-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03526-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03526-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T15:38:41Z","timestamp":1788277121000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03526-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,9,20]]}},"alternative-id":["3526"],"URL":"https:\/\/doi.org\/10.1038\/s41416-026-03526-7","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"20 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All animal experiments were performed in accordance with the relevant guidelines and regulations. This research has been approved by the Institutional Animal Care and Use Committee of Zhongshan Hospital, Fudan University (Approval No. B2022-194).","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}